China Health EV / EBITDA
Was ist das EV / EBITDA von China Health?
EV / EBITDA von China Health Group Inc. ist 7.21
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf HKSE im Vergleich zu China Health
Was macht China Health?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Unternehmen mit ev / ebitda ähnlich China Health
- Bowl America hat EV / EBITDA von 7.20
- Zhejiang Chang'an Renheng Technology Co hat EV / EBITDA von 7.20
- Intense Technologies hat EV / EBITDA von 7.20
- Zenitel NV hat EV / EBITDA von 7.20
- Next Solar Fund hat EV / EBITDA von 7.20
- DS Smith Plc hat EV / EBITDA von 7.21
- China Health hat EV / EBITDA von 7.21
- Bodal Chemicals hat EV / EBITDA von 7.21
- V2X Inc hat EV / EBITDA von 7.21
- Hertz Global hat EV / EBITDA von 7.21
- Information Services hat EV / EBITDA von 7.21
- Pathward Inc hat EV / EBITDA von 7.21
- Impellam PLC hat EV / EBITDA von 7.22